En español
NIDA

Menu

Publications

Quick Links

National Advisory Council Agenda

131st Meeting of the National Advisory Council on Drug Abuse

Neuroscience Center - Conference Rooms C & D
6001 Executive Boulevard, Bethesda, MD.

Individuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event, should contact Gillian Acca via email or phone at 301-827-5843 or through the Federal Relay (1-800-877-8339). Requests should be made at least five days in advance of the workshop.

February 13, 2019

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

9:00 a.m. Call to Order
Nora Volkow, M.D. Director, NIDA

Review of Policy and Procedures
Susan Weiss, Ph.D.
Executive Secretary
National Advisory Council on Drug Abuse
Director, Division of Extramural Research, NIDA
9:15 a.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Division of Therapeutics and Medical Consequences (DTMC)
Kurt Rasmussen, Ph.D., Director

Division of Neuroscience and Behavior (DNB)
Rita Valentino, Ph.D., Director

Division of Epidemiology, Services, and Prevention Research (DESPR)
Carlos Blanco, M.D., Ph.D., Director

Office of Translational Initiatives and Program Innovationa (OTIPI)
Elena Koustova, Ph.D., M.B.A., Director

10:15 a.m. Break

Videocast: https://videocast.nih.gov/summary.asp?live=31483

Open Session

10:30 a.m. Welcome and Opening Remarks
Nora Volkow, M.D. Director, NIDA
10:45 a.m. Director's Report
Nora Volkow, M.D. Director, NIDA
11:45 a.m. Discussion
Council Members
12:15 p.m. Lunch Break
1:30 p.m. HHS Efforts to Combat the Opioid Crisis
ADM Brett Giroir, M.D., Assistant Secretary for Health, U.S. Department of Health and Human Services
2:10 p.m. Changing the Culture to Address Sexual Harassment​ 
Carrie Wolinetz, Ph.D., Associate Director for Science Policy, NIH
2:40 p.m. Neural Circuit Dynamics of Brain States and Drug Action
Karl Deisseroth, M.D., Ph.D., D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences
Stanford University and NACDA Member
3:15 p.m.

Concept Clearances

  • Leveraging Big Data Science Approaches to Elucidate the Neurobiological Basis of Substance Use Disorder
    Susan Wright, Ph.D., Health Scientist Administrator, DNB   
  • Exploiting Precision Pharmacology Techniques to Understand Opioid Receptor Signaling in Specific Circuits, Cell Types, and Subcellular Compartments
    Olivier Berton, Ph.D., Health Scientist Administrator, DNB
  • The Rat Opioid Genome Project
    Amy Lossie, Ph.D., Health Scientist Administrator, DNB
  • Exploiting Single Cell Technologies to Understand HIV Replication, Latency, and Reservoirs in Substance Using Populations
    John Satterlee, Ph.D., Health Scientist Administrator, DNB
  • Data Coordination and Analysis Center for Single Cell and Other Molecular HIV/SUD Data
  • Assessing Effects of Cannabis on HIV/AIDS Pathogenesis
    Woody Lin, Ph.D., Health Scientist Administrator, DNB
  • Targeting Inflammasomes in Drug Abuse and HIV
    Anne Tsai, Ph.D., Health Scientist Administrator, DNB
  • Cohorts of HIV/AIDS and Substance Abusing Populations
    Rich Jenkins, Ph.D., Health Scientist Administrator, DESPR
  • PrEP for HIV Prevention among Substance Using Populations
  • Advancing the Study of Recovery Support Services for Those Treated with Medications for Opioid Use Disorder
    Sarah Duffy, Ph.D., Depputy Branch Chief, DESPR
  • Clinical Outcome Assessments for Clinical Trials in Substance Use Disorders
    Tanya Ramey, M.D., Ph.D., Medical Safety Officer, DTMC
  • Digital Health Technologies to Address the Social Determinants of Opioid Addiction
    Elena Koustova, Ph.D., M.B.A., Director, OTIPI
  • Blockchain Technology to Improve SUD Care
    Irina Sazonova Ph.D., Health Science Administrator, OTIPI
  • Rapid Assessment of Drug Abuse: Smart City Tool
    Irina Sazonova Ph.D., Health Science Administrator, OTIPI
4:15 p.m. Public Comments
4:30 p.m. Adjourn

This page was last updated January 2019